These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35400360)

  • 1. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):. PubMed ID: 35400360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with inv(16)/t(16;16)(p13.1;q22) and/or CBFβ-MYH11].
    Wang YM; Cai P; Zhou MJ; Gong YY; Pan JL; Cen JN; Yang XF; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):367-372. PubMed ID: 35395965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.
    Zhang W; Wang H; Zhang P; Li H; Ma X; Liu H
    Braz J Med Biol Res; 2021; 54(12):e11605. PubMed ID: 34730684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Prognostic Factors for AML Children with CBFβ/MYH11 Positive].
    Yan M; Song FX; Lu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):369-373. PubMed ID: 33812401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
    J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia].
    Liu L; Yang L; Mi YC; Li JY; Qin TJ; Xu ZF; Zhang Y; Wang JX; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):433-8. PubMed ID: 22213860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
    Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
    Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
    Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
    Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
    Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
    J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
    Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
    Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
    Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular Genetic Characteristics of Acute Myeloid Leukemia Patients with
    Jiang Y; Chao HY; Lu XZ; Wu P; Sun XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1661-1667. PubMed ID: 36476886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
    Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
    J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
    Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
    Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
    Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
    Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.